(6-chloro-2-methyl-4-phenyl-3-quinolyl)(piperidino)methanone | 1203506-45-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: (6-chloro-2-methyl-4-phenyl-3-quinolyl)(piperidino)methanone
• 英文别名: (6-chloro-2-methyl-4-phenylquinolin-3-yl)(piperidin-1-yl)methanone；(6-chloro-2-methyl-4-phenylquinolin-3-yl)-piperidin-1-ylmethanone
• CAS: 1203506-45-9
• 化学式: C₂₂H₂₁ClN₂O
• 分子量: 364.875
• InChiKey: VXCXYWVMPRHSLZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.1
• 重原子数：
  26
• 可旋转键数：
  2
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.27
• 拓扑面积：
  33.2
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  1-(哌啶-1-基)丁烷-1,3-二酮 、 2-氨基-5-氯二苯甲酮 在 ytterbium(III) triflate 作用下， 以 乙醇 为溶剂， 反应 12.0h， 以48%的产率得到(6-chloro-2-methyl-4-phenyl-3-quinolyl)(piperidino)methanone
  参考文献：
  名称：

  SUBSTITUTED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS

  摘要：

  本发明涉及具有以下结构的钠通道抑制剂（I）：其中R1、R2、R3、R4、R5、X、Y和Z如本文所定义，并且其在治疗各种疾病状态中的使用，包括心血管疾病和糖尿病。该发明还涉及制备这些化合物的方法，以及含有这些化合物的药物组合物。

  公开号：

  US20100125091A1

文献信息

• Substituted heterocyclic compounds as ion channel modulators
  申请人：Gilead Sciences, Inc.

  公开号：US08664399B2

  公开（公告）日：2014-03-04

  The present invention relates to sodium channel inhibitors of Formula (I): in which R1, R2, R3, R4, R5, X, Y, and Z are as defined herein, and to their use in the treatment of various disease states, including cardiovascular diseases and diabetes. The invention also relates to methods for the preparation of the compounds, and to pharmaceutical compositions containing such compounds.

  本发明涉及式(I)的钠通道抑制剂：其中R1，R2，R3，R4，R5，X，Y和Z如本文所定义，并且其在治疗各种疾病状态中的使用，包括心血管疾病和糖尿病。该发明还涉及制备这些化合物的方法，以及含有这些化合物的制药组合物。
• Diversity-Oriented Synthesis of Quinolines via Friedländer Annulation Reaction under Mild Catalytic Conditions
  作者：D. Subhas Bose、Mohd. Idrees、N. M. Jakka、J. Venkateswara Rao

  DOI：10.1021/cc900129t

  日期：2010.1.11

  An efficient and practical method has been manifested for the diversity-oriented synthesis of quinolines via Friedlander annulation reaction for the generation of a wide range of structurally interesting and pharmacologically significant compounds by using ceric ammonium nitrate as a catalyst (10 mol %) at ambient temperature in 45 min. A variety of functional groups are introduced at various positions of the quinoline moiety, and further the diversity of the core skeleton was expanded at R-1 and R-2 positions by the synthesis of various hybrids. Initial screening of the compounds for cytotoxicity against a series of cancer cell lines showed promising results,
• US8664399B2
  申请人：——

  公开号：US8664399B2

  公开（公告）日：2014-03-04
• US8865739B2
  申请人：——

  公开号：US8865739B2

  公开（公告）日：2014-10-21
• [EN] QUINOLINE DERIVATIVES AS ION CHANNEL MODULATORS<br/>[FR] DÉRIVÉS DE QUINOLÉINE AU TITRE DE MODULATEURS DE CANAUX IONIQUES
  申请人：GILEAD PALO ALTO INC

  公开号：WO2010056865A1

  公开（公告）日：2010-05-20

  The present invention relates to sodium channel inhibitors of Formula (I): in which R1, R2, R3, R4, R5, X, Y, and Z are as defined herein, and to their use in the treatment of various disease states, including cardiovascular diseases and diabetes. The invention also relates to methods for the preparation of the compounds, and to pharmaceutical compositions containing such compounds.